Evaluating Cigarette Relighting Behavior: Prevalence, Correlates, Toxicant Exposure, and Implications for Cessation
评估重新点燃香烟的行为:流行率、相关性、有毒物质暴露以及对戒烟的影响
基本信息
- 批准号:10570252
- 负责人:
- 金额:$ 63.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-15 至 2026-01-31
- 项目状态:未结题
- 来源:
- 关键词:AbstinenceAddressAdultAffectAmericanBackBehaviorBehavior TherapyBehavioralCarbon MonoxideCarcinogensChronic BronchitisCigaretteCigarette SmokerClinicClinicalCompensationDataData AnalysesDedicationsDependenceDisparityDoseEconomicsEducationEnvironmentEpidemiologyEvaluationExhalationExposure toFormaldehydeFoundationsFrequenciesFutureHarm ReductionHealthHealth BenefitHealth StatusHigh PrevalenceIndividualInternational Agency for Research on CancerInterventionKnowledgeLeadLightingMalignant neoplasm of lungMeasurementMeasuresMental HealthMotivationNicotineNicotine DependenceOutcomeParticipantPatternPharmacological TreatmentPharmacotherapyPilot ProjectsPopulationPrevalenceProviderPublic HealthReportingResearchRiskSamplingScienceSmokeSmokerSmokingSmoking BehaviorSmoking Cessation InterventionSubgroupSurveysTimeTobaccoTobacco DependenceTobacco IndustryTobacco SurveillanceTobacco Use CessationTobacco-Associated CarcinogenToxic effectToxicant exposurecigarette smokecontextual factorscostdisenfranchised populationexperimental grouphealth disparityhigh risklow socioeconomic statuspharmacologicpopulation surveyprimary outcomeprospectiveresponsesmoking cessationsmoking prevalencesuccesstobacco controltobacco exposuretobacco toxicanttoxicanttreatment and outcometreatment comparisontreatment programtreatment strategy
项目摘要
Although smoking prevalence has decreased, more than 34 million Americans continue to smoke. Disenfranchised groups increasingly comprise the remaining smoking population, and cigarette relighters may be some of the most disenfranchised (e.g., low socioeconomic status). Relighting refers to extinguishing, saving, and later relighting unfinished cigarettes. Research suggests this is a prevalent behavior engaged in by 44-73% of smokers, with 17-21% of smokers reporting they relight ‘usually’ or ‘frequently’, thus impacting millions of Americans. Apparent reasons for relighting include cost, perceived benefits for health and cessation, and smoking bans. This behavior may increase harms to smokers such as lung cancer and chronic bronchitis. For example, relighting could contribute to worse cessation and health outcomes if relighters (who tend to be highly nicotine-dependent) have lower motivation toward total abstinence because they believe they are minimizing the amount they smoke. They may also be inadequately treated and advised by clinicians because they appear to be less dependent or smoke fewer numbers of cigarettes per day (CPD) compared to non-relighters, despite a greater number of smoking sessions per day and exposure to toxicants. This could lead to under-dosing of pharmacotherapy. Given that reasons for relighting include the increasing cost of cigarettes, prevalence of relighting may grow in the future (especially during this economic crisis) and may continue to impact disproportionately those with greater existing tobacco-related disparities. More research is needed to address these challenges by investigating who relights and why, and potential effects of relighting on tobacco dependence, cessation, and health. Understanding relighting is critical because: 1) current assessments (i.e., CPD) may underestimate toxicant exposure and nicotine dependence among relighters and 2) if relighting continues to be largely ignored by providers, a high proportion of smokers may be undertreated. Specific aims of this four-year project are to: 1) Establish criteria and reasons for, as well as prevalence, frequency, and correlates of relighting in a national survey; 2) Evaluate potential toxic effects of relighting using topography and toxicant analyses; 3) Investigate the potential impact of relighting by observing tobacco treatment and outcomes of relighters in a state-wide tobacco treatment program. Preliminary studies need to be replicated and extended to be more rigorous, comprehensive, and on a larger scale to address numerous remaining questions that would lay the groundwork for understanding the individual and public health impact of relighting. This study will provide important information about the extent, frequency, contextual factors, and potential dangers of this understudied behavior. The study has implications for both surveillance and treatment such as new measures to screen for relighting clinically and in population surveys as well as potentially informing clinicians in prescribing appropriate-intensity treatments for relighters. Together, data from the proposed specific aims will provide a clearer picture of the extent and impact of cigarette relighting.
尽管吸烟率有所下降,但仍有超过 3400 万美国人继续吸烟。被剥夺权利的群体越来越多地包括剩余的吸烟人口,而重新点燃香烟的人可能是最被剥夺权利的群体之一(例如,社会经济地位较低)。重新点燃是指将未抽完的香烟熄灭、保存并随后重新点燃。研究表明,这是 44-73% 吸烟者普遍存在的行为,其中 17-21% 的吸烟者表示他们“通常”或“经常”重新吸烟,从而影响了数百万美国人。重新点燃的明显原因包括成本、对健康和戒烟的好处以及禁烟令。这种行为可能会增加吸烟者罹患肺癌、慢性支气管炎等危害。例如,如果重新点燃者(往往高度依赖尼古丁)完全戒烟的动机较低,因为他们相信自己正在最大限度地减少吸烟量,那么重新点燃可能会导致更糟糕的戒烟和健康结果。他们也可能没有得到临床医生的充分治疗和建议,因为尽管每天吸烟次数较多且接触有毒物质,但与非重新点燃者相比,他们似乎依赖性较低或每天吸烟数量 (CPD) 较少。这可能导致药物治疗剂量不足。鉴于重新点燃的原因包括卷烟成本的增加,重新点燃的流行率在未来可能会增加(特别是在这场经济危机期间),并且可能继续对那些现有烟草相关差异较大的人产生不成比例的影响。需要进行更多研究来应对这些挑战,调查谁重新吸烟、原因以及重新吸烟对烟草依赖、戒烟和健康的潜在影响。了解重新点燃至关重要,因为:1) 当前的评估(即 CPD)可能低估了重新点燃者的毒物暴露和尼古丁依赖性,2) 如果重新点燃继续被提供者忽视,很大一部分吸烟者可能得不到充分治疗。这个为期四年的项目的具体目标是: 1) 在全国调查中建立重新点燃的标准和原因以及流行率、频率和相关性; 2) 使用地形和毒物分析评估重新照明的潜在毒性影响; 3) 通过观察全州烟草治疗计划中的烟草治疗和重新点燃者的结果,调查重新点燃的潜在影响。初步研究需要进行重复和扩展,以更加严格、全面和更大规模,以解决许多遗留问题,为理解重新照明对个人和公共健康的影响奠定基础。这项研究将提供有关这种未被充分研究的行为的程度、频率、背景因素和潜在危险的重要信息。该研究对监测和治疗都有影响,例如临床和人口调查中筛查重新点燃的新措施,以及可能为临床医生为重新点燃者开出适当强度的治疗处方提供信息。总之,来自拟议具体目标的数据将更清楚地了解重新点燃卷烟的程度和影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Carolyn Heckman其他文献
Carolyn Heckman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Carolyn Heckman', 18)}}的其他基金
Evaluating sexual orientation and gender identity measurement methods to improve research on cigarette relighting
评估性取向和性别认同测量方法以改进卷烟重新点燃的研究
- 批准号:
10831217 - 财政年份:2023
- 资助金额:
$ 63.52万 - 项目类别:
Evaluating Cigarette Relighting Behavior: Prevalence, Correlates, Toxicant Exposure, and Implications for Cessation
评估重新点燃香烟的行为:流行率、相关性、有毒物质暴露以及对戒烟的影响
- 批准号:
10390029 - 财政年份:2022
- 资助金额:
$ 63.52万 - 项目类别:
A digital intervention to improve skin self-examination among melanoma survivors
改善黑色素瘤幸存者皮肤自我检查的数字干预
- 批准号:
10593971 - 财政年份:2022
- 资助金额:
$ 63.52万 - 项目类别:
A digital intervention to improve skin self-examination among melanoma survivors
改善黑色素瘤幸存者皮肤自我检查的数字干预
- 批准号:
10446546 - 财政年份:2022
- 资助金额:
$ 63.52万 - 项目类别:
Modifying Young Adult Skin Cancer Risk and Protective Behaviors (UV4.me2):A Hybrid Type 2 Dissemination/Effectiveness Trial
改变年轻成人皮肤癌风险和保护行为 (UV4.me2):2 型传播/有效性混合试验
- 批准号:
10050020 - 财政年份:2016
- 资助金额:
$ 63.52万 - 项目类别:
Modifying Young Adult Skin Cancer Risk and Protective Behaviors (UV4.me2): A Hybrid Type 2 Dissemination/Effectiveness Trial
改变年轻成人皮肤癌风险和保护行为 (UV4.me2):2 型传播/有效性混合试验
- 批准号:
9237721 - 财政年份:2016
- 资助金额:
$ 63.52万 - 项目类别:
A Tailored Internet Intervention for Skin Cancer Risk Reduction in Young Adults
降低年轻人皮肤癌风险的定制互联网干预措施
- 批准号:
8625271 - 财政年份:2011
- 资助金额:
$ 63.52万 - 项目类别:
A Tailored Internet Intervention for Skin Cancer Risk Reduction in Young Adults
降低年轻人皮肤癌风险的定制互联网干预措施
- 批准号:
8022322 - 财政年份:2011
- 资助金额:
$ 63.52万 - 项目类别:
A Tailored Internet Intervention for Skin Cancer Risk Reduction in Young Adults
降低年轻人皮肤癌风险的定制互联网干预措施
- 批准号:
8230588 - 财政年份:2011
- 资助金额:
$ 63.52万 - 项目类别:
A Tailored Internet Intervention for Skin Cancer Risk Reduction in Young Adults
降低年轻人皮肤癌风险的定制互联网干预措施
- 批准号:
8444587 - 财政年份:2011
- 资助金额:
$ 63.52万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 63.52万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 63.52万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 63.52万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 63.52万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 63.52万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 63.52万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 63.52万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 63.52万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 63.52万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 63.52万 - 项目类别:
Research Grant














{{item.name}}会员




